Data as of Jul 24
| +0.22 / +0.65%|
The 28 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 37.48, with a high estimate of 42.29 and a low estimate of 29.33. The median estimate represents a +10.83% increase from the last price of 33.82.
The current consensus among 32 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.